Tongling Jieya Biologic Technology Co., Ltd.

SZSE:301108 Stock Report

Market Cap: CN¥2.0b

Tongling Jieya Biologic Technology Management

Management criteria checks 2/4

Tongling Jieya Biologic Technology's CEO is Yingchuan Cai, appointed in Jun 2019, has a tenure of 5.58 years. directly owns 53.42% of the company’s shares, worth CN¥1.07B. The average tenure of the management team and the board of directors is 5.6 years and 2.6 years respectively.

Key information

Yingchuan Cai

Chief executive officer

CN¥1.4m

Total compensation

CEO salary percentagen/a
CEO tenure5.6yrs
CEO ownership53.4%
Management average tenure5.6yrs
Board average tenure2.6yrs

Recent management updates

Recent updates

Tongling Jieya Biologic Technology Co., Ltd.'s (SZSE:301108) Price Is Out Of Tune With Earnings

Dec 20
Tongling Jieya Biologic Technology Co., Ltd.'s (SZSE:301108) Price Is Out Of Tune With Earnings

Be Wary Of Tongling Jieya Biologic Technology (SZSE:301108) And Its Returns On Capital

Sep 28
Be Wary Of Tongling Jieya Biologic Technology (SZSE:301108) And Its Returns On Capital

CEO

Yingchuan Cai (55 yo)

5.6yrs

Tenure

CN¥1,390,000

Compensation

Mr. Yingchuan Cai is Chairman of the Board & GM of Tongling Jieya Biologic Technology Co. Ltd. from June 28, 2019.


Leadership Team

NamePositionTenureCompensationOwnership
Yingchuan Cai
Chairman of the Board & GM5.6yrsCN¥1.39m53.42%
CN¥ 1.1b
Fanlong Yang
CFO & Director2.8yrsCN¥454.40kno data
Ying Ye
Deputy GM & Director5.6yrsCN¥1.26m0.21%
CN¥ 4.2m
Nenghua Hu
Deputy GM & Board Secretary5.6yrsCN¥385.60k0.21%
CN¥ 4.2m

5.6yrs

Average Tenure

51.5yo

Average Age

Experienced Management: 301108's management team is seasoned and experienced (5.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yingchuan Cai
Chairman of the Board & GM5.6yrsCN¥1.39m53.42%
CN¥ 1.1b
Fanlong Yang
CFO & Director2.6yrsCN¥454.40kno data
Ying Ye
Deputy GM & Director5.6yrsCN¥1.26m0.21%
CN¥ 4.2m
Yancheng Yu
Supervisor5.6yrsno datano data
Yan Feng
Director5.6yrsCN¥174.80k2.69%
CN¥ 54.0m
Xianguo Yuan
Director5.6yrsCN¥366.40k0.21%
CN¥ 4.2m
Yan Chen
Independent Director2.6yrsCN¥60.00kno data
Bo Zhao
Independent Director2.6yrsCN¥60.00kno data
Ting Wang
Director2.6yrsCN¥244.50kno data
Wenlong He
Independent Director2.6yrsCN¥60.00kno data
Lixia Jiang
Employee Supervisor2.6yrsno datano data
Yunfeng Lu
Chairman of the Supervisory Board2.6yrsno datano data

2.6yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 301108's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 04:14
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tongling Jieya Biologic Technology Co., Ltd. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhuonan XuChina International Capital Corporation Limited
Pu HuiChina International Capital Corporation Limited